Robert J. Meyer
Director · Avalyn Pharma Inc.
Individual
- 2025
- Sep 17, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert J. Meyer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- SR ONE CAPITAL MANAGEMENT, LLC - $10.00M in AVLN purchases and sales in the last 12 months
- Novo Holdings A/S - $10.00M in AVLN purchases and sales in the last 12 months
- Jill Carroll - $5.00M in AVLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert J. Meyer?
Robert J. Meyer is a corporate insider, tracked as Director of Avalyn Pharma Inc. (AVLN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Robert J. Meyer submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
